Sign In
Buy OPK
$1.46
+0.0600 (+4.29%)
At Close: Jun 03, 2026
Reviewing OPKO Health (NASDAQ:OPK) and Coloplast A/S (OTCMKTS:CLPBY)
02:32am, Thursday, 12'th Feb 2026
Coloplast A/S (OTCMKTS:CLPBY - Get Free Report) and OPKO Health (NASDAQ: OPK - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
08:00am, Wednesday, 04'th Feb 2026
This is the third program that s uccessfully combine s Entera's oral peptide N- Tab ® platform with OPKO 's advanced protein chemistry capabilities
OPKO Health: Deeply Mispriced Ahead Of Major Catalysts
04:03am, Tuesday, 27'th Jan 2026
I believe OPKO Health will end 2026 on a high note. In partnership with Merck, Regeneron, and BARDA, it is developing ModeX's product candidates aimed at treating COVID-19, influenza, solid tumors, an
OPKO Health (NASDAQ:OPK) Shares Cross Below Fifty Day Moving Average – Here’s Why
04:52am, Friday, 16'th Jan 2026
OPKO Health, Inc. (NASDAQ: OPK - Get Free Report) shares passed below its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $1.32 and traded as low as $1
OPKO Health (NASDAQ:OPK) & Positron (OTCMKTS:POSC) Head-To-Head Review
01:22am, Friday, 16'th Jan 2026
Positron (OTCMKTS:POSC - Get Free Report) and OPKO Health (NASDAQ: OPK - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesse
OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
05:45am, Thursday, 15'th Jan 2026
OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
04:11pm, Tuesday, 06'th Jan 2026
MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK ) announced today that management will be participating in the 44th Annual J.P. Morgan Healthcare Conference, being held January
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth
08:06am, Tuesday, 06'th Jan 2026
OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk.
Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now
08:31am, Tuesday, 09'th Dec 2025
OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk.
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
04:05pm, Wednesday, 19'th Nov 2025
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37th Annual Healthcare Conference, being held Decemb
OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands
01:26pm, Thursday, 30'th Oct 2025
OPKO Health's Q3 earnings top estimates despite lower sales. Cost cuts and product strength boost margins and operating income.
OPKO Health, Inc. (OPK) Q3 2025 Earnings Call Transcript
09:36pm, Wednesday, 29'th Oct 2025
OPKO Health, Inc. ( OPK ) Q3 2025 Earnings Call October 29, 2025 4:30 PM EDT Company Participants Phillip Frost - Chairman & CEO Elias Zerhouni - President & Vice Chairman Adam Logal - Senior VP & CFO
Compared to Estimates, OPKO Health (OPK) Q3 Earnings: A Look at Key Metrics
07:31pm, Wednesday, 29'th Oct 2025
While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics co
OPKO Health (OPK) Q3 Earnings Surpass Estimates
06:41pm, Wednesday, 29'th Oct 2025
OPKO Health (OPK) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.03 per share a year ago.
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
04:05pm, Wednesday, 29'th Oct 2025
MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights fro
